European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.
نویسندگان
چکیده
Ignace Vergote, MD, PhD,* Eric Pujade-Lauraine, MD,* Sandro Pignata, MD,* Gunnar B. Kristensen, MD,* Jonathan Ledermann, MD,* Antonio Casado, MD,* Jalid Sehouli, MD,* Mansoor Mirza, MD,* Roldano Fossati, MD,* Christian Marth, MD,* Carine Creutzberg, MD,* Jose Del Campo, MD,* Nadeem Siddiqui, MD,* Paula Calvert, MD,* Aris Bamias, MD,* Gokhan Tulunay, MD,* Ate G.J. van der Zee, MD,* and Andreas du Bois, MD,* on behalf of the member trial groups of the European Network of Gynaecological Oncological Trial Groups (ENGOT)
منابع مشابه
Fast-track surgery after gynaecological oncological surgery: study protocol for a prospective randomised controlled trial
BACKGROUND Fast-track surgery (FTS), also known as enhanced recovery after surgery, is a multidisciplinary approach to accelerate recovery, reduce complications, minimise hospital stay without increasing readmission rates, and reduce health care costs, all without compromising patient safety. The advantages of FTS in abdominal surgery most likely extend to gynaecological surgery, but this is an...
متن کاملEfficacy of Generic Granisetron vs Kytril® for PONV in Major Gynecological Operations: A Randomized, Double-blind Clinical Trial
Background Granisetron is a first-generation 5-HT3-receptor antagonist that has shown efficacy in preventing postoperative nausea and vomiting (PONV). In this randomized double-blind parallel-group clinical trial, we assessed the efficacy of generic granisetron versus Kytril®, in the prevention of PONV in patients undergoing general anesthesia for gynaecological surgeries. Method One hundred an...
متن کاملEfficacy of Generic Granisetron vs Kytril® for PONV in Major Gynecological Operations: A Randomized, Double-blind Clinical Trial
Background Granisetron is a first-generation 5-HT3-receptor antagonist that has shown efficacy in preventing postoperative nausea and vomiting (PONV). In this randomized double-blind parallel-group clinical trial, we assessed the efficacy of generic granisetron versus Kytril®, in the prevention of PONV in patients undergoing general anesthesia for gynaecological surgeries. Method One hundred an...
متن کاملCommentary on "increasing minority participation in clinical research": a white paper from the endocrine society.
Underrepresentation of racial and ethnic minorities in clinical research limits the applicability of trial results to diverse subpopulations. Recognizing an ongoing need to increase participation by minorities, The Endocrine Society established a task force of thought leaders from all stakeholder groups—the pharmaceutical industry, federal agencies, academia, and community groups—to develop a w...
متن کاملPerforming phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.
Drug discovery and early clinical development is an international endeavor, conducted in partnership between commercial entities such as biotechnology and pharmaceutical companies and academic investigators. Although once considered quite disparate, early clinical trials requirements and conduct are largely harmonized between the European Union, Japan, and the United States, increasing the oppo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
دوره 20 3 شماره
صفحات -
تاریخ انتشار 2010